Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 83Neoplasms, Plasma Cell 54Leukemia 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma 45Hodgkin Disease 45Myelodysplastic Syndromes 44Lymphoma, Non-Hodgkin 43Leukemia, Myeloid, Acute 43Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma, Follicular 35Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Mantle-Cell 32Lymphoma, B-Cell, Marginal Zone 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 30Congenital Abnormalities 30Burkitt Lymphoma 30Primary Myelofibrosis 27Myeloproliferative Disorders 27Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myelomonocytic, Chronic 24Blast Crisis 24Recurrence 21Lymphoma, T-Cell, Cutaneous 18Dendritic Cell Sarcoma, Interdigitating 18Waldenstrom Macroglobulinemia 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Myelodysplastic-Myeloproliferative Diseases 16Pdgfra-Associated Chronic Eosinophilic Leukemia 14

Interventions

Dexamethasone 12Bortezomib 9Lenalidomide 6Cyclophosphamide 5isatuximab 3fludarabine 3daratumumab 3Granulocyte Colony-Stimulating Factor 3pomalidomide 2filanesib 2dacetuzumab 2Tacrolimus 2Steroids 2Injections, Subcutaneous 2Filgrastim 2Clinical Protocols 2Calcium Dobesilate 2Alemtuzumab 2plerixafor 1nirogacestat 1fludarabine phosphate 1ficlatuzumab 1birtamimab 1Zoledronic Acid 1Whole-Body Irradiation 1Vorinostat 1Tissue Banks 1Thalidomide 1Stem Cell Transplantation 1Ranitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Busulfan × Plasma cell × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡